NCT07080944View on ClinicalTrials.gov

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC

NANot yet recruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

July 31, 2030

Study Completion Date

August 31, 2030

Conditions
Invasive Breast CarcinomaSentinel Lymph Node Biopsy (SLNB)Neoadjuvant Chemotherapy
Interventions
PROCEDURE

SLN identification using technetium-99m

SLN Biopsy after pre-surgery positive SLN visualization.

PROCEDURE

SLN intra-operatory identification with radioguided surgery

SLN biopsy after no pre-surgery SLN visualization using technetium-99m and intra-surgery SLN identification.

PROCEDURE

Axillary Limph Node Dissection (ALND)

Axillary Limph Node Dissection (ALND) after no pre-surgery SLN visualization using technetium-99m and no intra-surgery SLN identification.

Trial Locations (1)

20141

European Institute of Oncology, Milan

All Listed Sponsors
lead

European Institute of Oncology

OTHER

NCT07080944 - Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC | Biotech Hunter | Biotech Hunter